The mean time to second recurrence was 10.8 months (95% CI: 6.8–14.9) in IDH-mutant astrocytomas and 8.1 months (95% CI: 6.2–10.0) in IDHwt GBM. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).